Novel PET/CT Imaging Agent Explored for Cardiac Amyloidosis Diagnosis

AI-generated NewsSnap summary based on source reporting.
Published: 2026-08-30
Category: health
Source: JAMA / PubMed
Original source

The REVEAL study, a nonrandomized clinical trial published in JAMA, investigated the 124I-Evuzamitide PET/CT method for diagnosing cardiac amyloidosis in 170 patients. This research aims to assess the sensitivity and specificity of a novel imaging agent, potentially improving the accuracy and timeliness of diagnosing this serious heart condition.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai